Literature DB >> 21193427

In search of the optimal iron chelation therapy for patients with thalassemia major.

Vasilios Berdoukas, John Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21193427      PMCID： PMC3012756          DOI： 10.3324/haematol.2010.034397

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  25 in total

1.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

2.  Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload.

Authors:  Dudley J Pennell; John B Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi-Kong Li; Vip Viprakasit; Mohsen Saleh Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher
Journal:  Haematologica       Date:  2010-11-11       Impact factor: 9.941

3.  Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia.

Authors:  Lisa J Anderson; Beatrix Wonke; Emma Prescott; Sally Holden; J Malcolm Walker; Dudley J Pennell
Journal:  Lancet       Date:  2002-08-17       Impact factor: 79.321

4.  Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.

Authors:  Dudley J Pennell; John B Porter; Maria Domenica Cappellini; Amal El-Beshlawy; Lee Lee Chan; Yesim Aydinok; Mohsen Saleh Elalfy; Pranee Sutcharitchan; Chi-Kong Li; Hishamshah Ibrahim; Vip Viprakasit; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher
Journal:  Blood       Date:  2009-12-08       Impact factor: 22.113

5.  The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores.

Authors:  John C Wood; Barinder P Kang; Alexis Thompson; Patricia Giardina; Paul Harmatz; Tara Glynos; Carole Paley; Thomas D Coates
Journal:  Blood       Date:  2010-04-26       Impact factor: 22.113

6.  Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.

Authors:  Alessia Pepe; Antonella Meloni; Marcello Capra; Paolo Cianciulli; Luciano Prossomariti; Cristina Malaventura; Maria Caterina Putti; Alma Lippi; Maria Antonietta Romeo; Maria Grazia Bisconte; Aldo Filosa; Vincenzo Caruso; Antonella Quarta; Lorella Pitrolo; Massimiliano Missere; Massimo Midiri; Giuseppe Rossi; Vincenzo Positano; Massimo Lombardi; Aurelio Maggio
Journal:  Haematologica       Date:  2010-09-30       Impact factor: 9.941

7.  Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel.

Authors:  Vito Di Marco; Marcello Capra; Emanuele Angelucci; Caterina Borgna-Pignatti; Paul Telfer; Paul Harmatz; Antonis Kattamis; Luciano Prossamariti; Aldo Filosa; Deborah Rund; Maria Rita Gamberini; Paolo Cianciulli; Marianne De Montalembert; Francesco Gagliardotto; Graham Foster; Jean Didier Grangè; Filippo Cassarà; Angela Iacono; Maria Domenica Cappellini; Gary M Brittenham; Daniele Prati; Antonello Pietrangelo; Antonio Craxì; Aurelio Maggio
Journal:  Blood       Date:  2010-06-15       Impact factor: 22.113

Review 8.  Update on survival in thalassemia major.

Authors:  Paul Telfer
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

9.  Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit.

Authors:  Vassilios Ladis; Giorgos Chouliaras; Vasilios Berdoukas; Panagiotis Moraitis; Kirykos Zannikos; Eleni Berdoussi; Christos Kattamis
Journal:  Eur J Haematol       Date:  2010-08-30       Impact factor: 2.997

10.  Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.

Authors:  Kallistheni Farmaki; Ioanna Tzoumari; Christina Pappa; Giorgos Chouliaras; Vasilios Berdoukas
Journal:  Br J Haematol       Date:  2009-11-12       Impact factor: 6.998
View more
  1 in total

1.  Iron depletion: an ameliorating factor for sickle cell disease?

Authors:  P C Giordano; W Huisman; C L Harteveld
Journal:  ISRN Hematol       Date:  2011-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.